NRX Pharmaceuticals, Inc.Interim Ceo Appointment Agreement • March 9th, 2022 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 9th, 2022 Company IndustryThis letter agreement (the “Agreement”) supplements the Work for Hire Agreement entered into by and between REBes Consulting LLC- Robert Besthof (“Consultant”) and NeuroRx, Inc., dated March 1, 2016 as amended on October 23, 2020 (the “Consulting Agreement”). The purpose of this Agreement is to confirm your appointment as the Interim Chief Executive Officer of NRX Pharmaceuticals, Inc. (the “Company”) beginning on the March 8, 2022 (the “Effective Date”). While providing services as Interim Chief Executive Officer, you will continue to be provide services pursuant to the Consulting Agreement and you will also continue to serve as the Chief Commercial and Patient Officer and Head of Operations. Any capitalized terms used in this Agreement without definition will have the same meaning as in the Consulting Agreement.
ContractConsulting Agreement • March 9th, 2022 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 9th, 2022 Company Industry JurisdictionCONSULTING AGREEMENT (this “Agreement”) effective as of March 8, 2022 (the “Effective Date”), between NRX Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Jonathan C. Javitt (“Consultant”).